Pharma & Biotech

All attention is focused on Ocugen as the biotechnology firm approaches a potentially defining moment. The coming week could set...

Shares of Assembly Biosciences have quietly delivered staggering returns this year, appreciating by more than 120% since January. While the...

The coming days represent a pivotal moment for BioNTech SE. The biotech firm is entering the final phase of its...

The biotechnology sector has a new standout performer, with ImmunityBio capturing significant investor attention. While numerous pharmaceutical stocks continue to...

Eli Lilly has become the first pharmaceutical company in history to achieve a market capitalization exceeding one trillion dollars. This...

The curtain is closing on CureVac's independent presence in the stock market. Following a conclusive shareholder decision this week, the...

Friday's trading session brought a significant surge for Adicet Bio, with its shares climbing 7.85% to close at $0.6482. While...

The biotechnology sector frequently trades on future potential, but investors in BioNxt Solutions encountered stark financial realities this Friday. The...

BioNTech faces a pivotal week as significant corporate developments converge. The impending deadline for the CureVac acquisition coincides with substantial...

Once hailed as a promising contender in the rapidly expanding online pharmacy sector, Redcare Pharmacy is now confronting a severe...